Abstract
We examined the prognostic value of early serum CA125 assay in 58 patients with advanced epithelial ovarian cancer together with residual disease, age, tumour grade, performance status, and the presence of ascites or adhesions at primary surgery. CA125 was a highly significant predictor of both progression free and overall survival after the first cycle and throughout primary chemotherapy. After the first cycle, CA125 was by far the most significant predictor of progression free survival (P < 0.0005). At this time, CA125 was a highly significant predictor of survival (P < 0.005), but did not add to performance status (P < 0.001) in multivariate analysis. We were able to identify three statistically-distinct prognostic groups. Patients in the upper quartile, with CA125 levels greater than 450 U ml-1, had a very poor median survival of 7 months. Patients in the lower quartile, with CA125 levels less than 55 U ml-1 had a good median survival of 23 months. Those in the two interquartile groups, who had CA125 levels ranging from 58-221 U ml-1 and 228-434 U ml-1, had relatively intermediate median survival times of 16 months and 15 months respectively. Although CA125 levels provided significant prognostic information, in the majority of patients CA125 merely confirmed overall clinical impression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fisken, J., Leonard, R., Stewart, M. et al. The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma. Br J Cancer 68, 140–145 (1993). https://doi.org/10.1038/bjc.1993.302
Issue Date:
DOI: https://doi.org/10.1038/bjc.1993.302
This article is cited by
-
CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review
Clinical and Translational Oncology (2016)
-
Determination of cancer antigen 125 in ovarian carcinoma
Indian Journal of Clinical Biochemistry (2003)
-
Serum CA 125 levels and survival in advanced ovarian cancer
Archives of Gynecology and Obstetrics (1997)